We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




A Histone Demethylase Regulates Stem Cell Differentiation

By LabMedica International staff writers
Posted on 06 Mar 2013
A recent publication detailed how the protein Fbxl10 regulates the maturation process that takes place when an embryonic stem cell differentiates into a specialized, functional tissue cell.

Fbxl10 is a histone demethylase enzyme that removes a methyl group from lysine-4' and lysine-36' of the histone H3. More...
Preferentially Fbxl10 removes methyl groups from trimethylated H3 lysine-4' and dimethylated H3 lysine-36' residues while it has weak or no activity for mono- or trimethylated H3 lysine-36'. Fbxl10 preferentially binds the transcribed region of ribosomal RNA and represses the transcription of ribosomal RNA genes which inhibits cell growth and proliferation.

In the paper published in the February 7, 2013, online edition of the journal Molecular Cell investigators at the University of Copenhagen (Denmark) found that to regulate stem cell maturation Fbxl10 directly recruits Polycomb Repressive Complex 1 proteins into CpG islands.

Polycomb-group (PcG) proteins are a family of proteins first discovered in fruit flies that can remodel chromatin so that epigenetic silencing of genes takes place. In humans, Polycomb Group gene expression is important in many aspects of development. Mouse mutants lacking PRC2 (Polycomb Repressive Complex 2) genes die as embryos while most PRC1 (Polycomb Repressive Complex 1) mutants are born alive but with anatomic rearrangements that cause them to die shortly after birth. In contrast, overexpression of PcG proteins correlates with the severity and invasiveness of several cancer types.

CpG islands are genomic regions that contain a high frequency of CpG sites. The "p" in CpG refers to the phosphodiester bond between the cytosine and the guanine residues, which indicates that the C and the G are next to each other in sequence, regardless of being single- or double-stranded. In a CpG site, both C and G are found on the same strand of DNA or RNA and are connected by a phosphodiester bond.

“Our new results show that this molecule is required for the function of one of the most important molecular switches that constantly regulates the activity of our genes. If Fbxl10 is not present in embryonic stem cells, the cells cannot differentiate properly, and this can lead to developmental defects,” said Dr. Kristian Helin, professor of health sciences at the University of Copenhagen.

Related Links:
University of Copenhagen




Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Collection and Transport System
PurSafe Plus®
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
New
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.